The FDA's MedWatch database had received more than 100 adverse event reports linked to compounded semaglutide as of late 2024, including cases of hypoglycemia, severe nausea requiring hospitalization, and one confirmed death under investigation
(11) N B Andersen, K Malmlf, P B Johansen, T T Andreassen, and G rtoft, H Oxlund (2001) The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats Growth Hormone and IGF Research, 2001 Oct, Volume 11 (Issue 5), Pages 266-72
and engineered with favorable pharmacokinetics for in vivo research
May your peptides stay potent, your storage stay cool, and your protocols stay effective
I wanted to sit down with him and ask the questions I knew our audience had but cant get straight answers on
BPC-157 and GHK-Cu are the leading candidates for this pillar